Treatment of Acute Pulmonary Blastomycosis in a Newborn with Evidence of Blastomycosis Infection
Acute pulmonary blastomycosis in a newborn is a serious clinical scenario requiring prompt, targeted management. When a neonate presents with evidence of blastomycosis infection, a specific antifungal treatment approach is recommended.
Clinical Scenario
A newborn with confirmed or suspected evidence of blastomycosis infection. This population requires a treatment strategy distinct from that used in older children or adults.
Treatment Approach
When the newborn shows evidence of infection, antifungal therapy with Amphotericin B deoxycholate is recommended.
Complete dosing, administration details, and the full clinical regimen are available in the structured protocol below.
References
DOI: 10.1086/588300
If the newborn shows evidence of infection, treatment is recommended with AmB deoxycholate, 1.0 mg/kg per day (A-III).